Using in vivo models of chronic metabolic conditions, such as obesity or cancer, LCN2 was associated with hippocampal neurotoxicity and cognitive impairment via neuroinflammation, oxidative stress, and blood–brain barrier (BBB) leakage [10,11]. The gene discussed is LCN2; the disease is obesity disorder.